Alexion Pharmaceuticals, Inc.
MONOVALENT ANTI-PROPERDIN ANTIBODIES AND ANTIBODY FRAGMENTS

Last updated:

Abstract:

Described herein are isolated monovalent antibodies or antibody fragments thereof that bind human properdin. Such antibodies are useful in methods of treatment for diseases mediated by alternative complement pathway dysregulation.

Status:
Application
Type:

Utility

Filling date:

9 Nov 2021

Issue date:

26 May 2022